Clinical Report: Utilizing Behaviorally Targeted Text Messaging to Enhance Colon Cancer Screening Rates
Overview
This study evaluated the effectiveness of behaviorally targeted text messaging in increasing fecal immunochemical test (FIT) completion rates among patients at Federally Qualified Health Centers (FQHCs). The findings suggest that this low-cost intervention can significantly improve screening uptake compared to standard telephone outreach.
Background
Colorectal cancer screening is crucial for early detection and reducing mortality, yet participation rates remain low, particularly among underserved populations. In 2023, only 72.6% of adults aged 50 to 75 were up to date with screening, with even lower rates observed in FQHCs. Innovative, scalable interventions are needed to address these disparities and improve screening rates.
Data Highlights
No numerical data was provided in the source material.
Key Findings
Behaviorally informed text message reminders significantly increased FIT completion rates compared to standard telephone outreach.
The study was conducted at a network of 8 FQHC sites serving over 100,000 patients annually.
Text messaging interventions can be easily adapted and refined over time, making them scalable for diverse healthcare settings.
Prior studies have shown that behavioral nudges effectively enhance screening uptake when combined with other outreach methods.
Low-income and minoritized populations particularly benefit from targeted interventions to improve screening rates.
Clinical Implications
Healthcare providers should consider implementing behaviorally targeted text messaging as a cost-effective strategy to enhance colorectal cancer screening rates, especially in underserved communities. This approach can help overcome logistical and cognitive barriers to screening.
Conclusion
The use of behaviorally targeted text messaging represents a promising intervention to improve colorectal cancer screening rates, addressing critical gaps in preventive care among underserved populations.
by Olivia Korostoff-Larsson, William C. King, Elan Pelegri, Doreen Colella, Isaac Dapkins, Kelly Eng, Nathan Klapheke, Holly Krelle, Nicholas Mahieu, Erika McManus, George Shahin, Molly Woodriff, Leora I. Horwitz, Arielle Elmaleh-Sachs
Colorectal cancer (CRC) impacts about 1 in 13,000 pregnancies in the United States. This article follows the case of a 36-year-old woman diagnosed with CRC while pregnant and highlights considerations around CRC diagnosis and cancer treatment during pregnancy.
